| CAT No: | CL-TFC-32 |
| CAS No: | 2459302-78-2 |
| Mol.F: | C34H45N7 |
| Mol.Wt.: | 551.78 |
| Rel. Cas No: | |
| Chemical Name: | N2,N4-bis((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N2,N4-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine |
| SMILES: | C[C@@H]1CCN(C[C@@H]1N(C)c2nc3[nH]ccc3c(n2)N(C)[C@H]4CN(CC[C@H]4C)Cc5ccccc5)Cc6ccccc6 |
| Inventory Status: | Custom synthesis |
This impurity is related to Tofacitinib Related Compound 9 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Tofacitinib Related Compound 9 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:N2,N4-bis((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N2,N4-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamineCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Tofacitinib Molecular Formula: C34H45N7
Molecular Weight: 551.78
Storage: Store in a cool, dry place.
| Product Name: | Tofacitinib Related Compound 9 |
| CAS No: | 2459302-78-2 |
| Mol.F.: | C34H45N7 |
| Mol.Wt.: | 551.78 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: